Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TN/Murfreesboro
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Murfreesboro, TN

Studies commonly pay $75 to $4,500 per completed study

79 clinical trials are currently recruiting participants within 30 miles of Murfreesboro. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

79studies recruiting
9+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Murfreesboro right now

Top 25 of 79 recruiting studies, sorted by proximity — each links to its official registry page

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

B-cell Acute Lymphoblastic Leukemia (B-ALL) Phase 1, Phase 2 Interventional 83 participants sought
Research Site — Franklin, Tennessee (26.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07109219)

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo Phase 3 Interventional 180 participants sought
International Clinical Research Tennessee Llc — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06548360)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Chronic Obstructive Pulmonary Disease (COPD) Phase 3 Interventional 990 participants sought
Research Site — Franklin, Tennessee (26.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06883305)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Vanderbilt-Ingram Cancer Center at Franklin — Franklin, Tennessee (26.1 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Breast Cancer, Locally Advanced Breast Cancer Phase 3 Interventional 1,000 participants sought
Clinical Trial Site — Mount Juliet, Tennessee (25.0 mi) · Sponsor: Olema Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07085767)

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Psychosis Associated With Alzheimer's Disease Phase 3 Interventional 410 participants sought
Local Institution - 1038 — Franklin, Tennessee (26.1 mi) · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See eligibility & contact on ClinicalTrials.gov (NCT05511363)

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Psoriatic Arthritis, Axial Spondyloarthritis Phase 1 Interventional 392 participants sought
Pa0019 138 — Murfreesboro, Tennessee (1.2 mi) · Sponsor: UCB Biopharma SRL
See eligibility & contact on ClinicalTrials.gov (NCT07290036)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NASH With Fibrosis, MASH With Fibrosis Phase 3 Interventional 1,650 participants sought
Akero Clinical Study Site — Hermitage, Tennessee (26.7 mi) · Sponsor: Akero Therapeutics, Inc
See eligibility & contact on ClinicalTrials.gov (NCT06215716)

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Acne Phase 1, Phase 2 Interventional 800 participants sought
DelRicht Research - Thompson's Station- Site Number : 8400041 — Smyrna, Tennessee (11.0 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company
See eligibility & contact on ClinicalTrials.gov (NCT06316297)

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis Phase 3 Interventional 675 participants sought
International Clinical Research - Tennessee /ID# 268548 — Murfreesboro, Tennessee (1.2 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06461897)

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis Phase 3 Interventional 1,700 participants sought
Clinical Trials Center of Middle Tennessee, LLC — Franklin, Tennessee (26.1 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT06238622)

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Major Depressive Disorder Phase 2 Interventional 164 participants sought
Psychiatric Consultants, PC — Franklin, Tennessee (26.1 mi) · Sponsor: Syndeio Biosciences, Inc
See eligibility & contact on ClinicalTrials.gov (NCT07115329)

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

Chronic Interstitial Cystitis, Bladder Pain Syndrome N/A Interventional 220 participants sought
Vanderbilt Urology Cool Springs — Franklin, Tennessee (26.1 mi) · Sponsor: Vanderbilt University Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT06299683)

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine Phase 3 Interventional 1,059 participants sought
Hawthorne Health - Lebanon /ID# 283149 — Lebanon, Tennessee (25.7 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT05125302)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Relapsing Multiple Sclerosis, Multiple Sclerosis N/A Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Spring Hill, Tennessee (29.8 mi) · Sponsor: TG Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06433752)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer Phase 1, Phase 2 Interventional 132 participants sought
Tennessee Oncology, PLLC - Murfreesboro — Murfreesboro, Tennessee (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07421700)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Multiple conditions Phase 2 Interventional 314 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT03866382)

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) Phase 2 Interventional 315 participants sought
Psychiatric Consultants - Franklin /ID# 275133 — Franklin, Tennessee (26.1 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06846320)
Google-rated

Top-rated research centers in Murfreesboro

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

International Clinical Research-Tennessee, LLC

★ 3.9
1035 N Highland Ave, Murfreesboro, TN 37130
(615) 410-3460
"I participated in an IC Research clinical study for a full year, and I can’t recommend them to anyone. On three separate occasions they failed to dis…"
— Hamid Ashari, 1★

Comprehensive Cancer Center

1840 Medical Center Pkwy, Murfreesboro, TN 37129
(615) 396-5530

MMC — Internal and Family Medicine

★ 4.9
1272 Garrison Dr, Murfreesboro, TN 37129
(615) 867-8010
"Very friendly staff they help you with any questions you may have."
— George R. Mcclain, 4★

Trustpoint Hospital

★ 2.7 (448 reviews)
1009 N Thompson Ln, Murfreesboro, TN 37129
(615) 716-1824
"So ghetto unprofessional don’t return phone calls lady that answered the phone this morning was very unprofessional believe what these reviews say th…"
— Twaina Woods, 1★

DelRicht Research of Thompson's Station Clinical Trials

★ 5.0
521 Stonecrest Pkwy #201, Smyrna, TN 37167
(504) 336-2667
"I absolutely would recommend them. Constance has made a magnificent impact on my short time here. All the nurses and Doctors been knowledgeable about…"
— Jaycie Oldham, 5★

Clinical Trials Center of Middle Tennessee

★ 5.0
100 Covey Dr, Franklin, TN 37067
(615) 205-8350
"We have been coming for over a year, and it has been a life changing experience, everyone is so friendly and helpful and easy to work with."
— Aggie Campbell, 5★

Clinical Research Solutions - Smyrna, TN

515 Stonecrest Pkwy #110, Smyrna, TN 37167
(615) 984-3365

HCCA Clinical Research

515 Stonecrest Pkwy, Smyrna, TN 37167
(615) 462-6346

Southeast Clinical Research

★ 5.0
224 Took Dr, Antioch, TN 37013
(615) 739-6512

Clinical trials in Murfreesboro: what's recruiting

The Murfreesboro area currently has 79 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Murfreesboro, the most active research areas are:

  • Cancer & Oncology7 studies
  • Immune & Skin3 studies
  • Brain & Mental Health3 studies
  • Lungs & Breathing2 studies
  • Liver & Kidney2 studies

Every listing shows the study phase, the recruiting site and its distance from Murfreesboro, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Murfreesboro

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Murfreesboro participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Murfreesboro pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Murfreesboro?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Murfreesboro?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Murfreesboro.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Murfreesboro typically complete one or two studies per year.

Paid clinical trials near Murfreesboro

Other metros within reach

Nashville, TN1,336 Huntsville, AL86 Clarksville, TN9 Chattanooga, TN146 Birmingham, AL962 Evansville, IN67 Louisville, KY576 Knoxville, TN223

More of TN

Nashville1,336 Memphis578 Knoxville223 Chattanooga146 Clarksville9

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts